Funded Tech Companies
Mimetogen Pharmaceuticals
Researching who provided funding to Mimetogen Pharmaceuticals? Medwell Capital invested in this innovative biopharmaceutical company.
Company Overview
Company Name
Mimetogen Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
67 Batterymarch St. 5th Floor
Boston, MA 02110
USA
Boston, MA 02110
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Mimetogen Pharmaceuticals is a venture-backed biotechnology company founded by Prof. H. Uri Saragovi and Dr. Garth Cumberlidge. The company is actively pursuing the development of novel small molecule compounds to treat neurodegenerative diseases of the eye, including dry eye, glaucoma and retinitis pigmentosa.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/22/2013
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Financial Officer
François Mongrain
VP - Bus. Development
Karen Meerovitch
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs